6526 - 6550 of 8654 Results
Title
Year
- Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury2014OPENTitle: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 1SStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4201593Citation Count: 69
-
OPENTitle: Cortical structural involvement and cognitive dysfunction in early Parkinson's diseaseJournal Name: NMR in BiomedicinePublisher: WileyVol: 31Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/nbm.3900Best OA location URL: https://ora.ox.ac.uk/objects/uuid:2905d363-4eee-4049-a1ec-b9df071ca9c0/files/md1f990179dc1b0f396affef57468ccaaCitation Count: 8
-
OPENTitle: Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 146Issue #: 1Start Page: 51End Page: 75Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-023-02585-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-023-02585-x.pdfCitation Count: 18
- Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease2021OPENTitle: Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00182-xBest OA location URL: https://www.nature.com/articles/s41531-021-00182-x.pdfCitation Count: 27
-
OPENTitle: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 3Start Page: e16End Page: e16Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awx378Best OA location URL: https://academic.oup.com/brain/article-pdf/141/3/e16/25046297/awx378.pdfCitation Count: 8
-
OPENTitle: Movement disorders in non-encephalopathic Hashimoto's thyroiditisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 141End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.008Best OA location URL: https://zenodo.org/record/3873759Citation Count: 17
- Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration2022OPENTitle: Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegenerationJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 4Start Page: e1010138End Page: e1010138Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1010138Best OA location URL: https://doi.org/10.1371/journal.pgen.1010138Citation Count: 8
- Treatment response to onabotulinumtoxinA in cervical dystonia patients with anterocollis and retrocollis2024OPENTitle: Treatment response to onabotulinumtoxinA in cervical dystonia patients with anterocollis and retrocollisJournal Name: ToxiconPublisher: Elsevier BVVol: 248Issue #:Start Page: 108035End Page: 108035Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.toxicon.2024.108035Best OA location URL: https://doi.org/10.1016/j.toxicon.2024.108035Citation Count: 2
- REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers2015OPENTitle: REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriersJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 13Start Page: 1834End Page: 1839Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26413Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4715645Citation Count: 34
-
RESTRICTEDTitle: Activity‐dependent secretion of alpha‐synuclein by enteric neuronsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 125Issue #: 4Start Page: 512End Page: 517Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.12131Citation Count: 96
-
OPENTitle: The Parkinson's Disease Genome‐Wide Association Study Locus BrowserJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2056End Page: 2067Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28197Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2021-00254%22Citation Count: 92
- LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis2020OPENTitle: LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosisJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.51071Best OA location URL: https://doi.org/10.7554/elife.51071Citation Count: 106
-
OPENTitle: Role of LRRK2 in the regulation of dopamine receptor traffickingJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 6Start Page: e0179082End Page: e0179082Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0179082Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179082&type=printableCitation Count: 67
-
OPENTitle: Mining the neuroimaging literatureJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.94909Best OA location URL: https://doi.org/10.7554/elife.94909Citation Count: 0
- Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein Fibrils2024OPENTitle: Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein FibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 18Start Page: 3270End Page: 3285Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00185Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11413846Citation Count: 1
-
RESTRICTEDTitle: Neurofibrillary tangles predict dementia in patients with carotid stenosisJournal Name: Journal of Vascular SurgeryPublisher: Elsevier BVVol: 81Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.jvs.2025.02.007Best OA location URL: https://doi.org/10.1016/j.jvs.2025.02.007Citation Count: 1
-
OPENTitle: Identification of small molecules that bind to the mitochondrial protein mitoNEETJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 21Start Page: 5350End Page: 5353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.09.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5482219Citation Count: 36
-
OPENTitle: CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2682End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23287Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978754Citation Count: 173
-
OPENTitle: Chalcones and Five-Membered Heterocyclic Isosteres Bind to Alpha Synuclein Fibrils in VitroJournal Name: ACS OmegaPublisher: American Chemical Society (ACS)Vol: 3Issue #: 4Start Page: 4486End Page: 4493Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acsomega.7b01897Best OA location URL: https://doi.org/10.1021/acsomega.7b01897Citation Count: 39
- Hippocampal, basal ganglia and olfactory connectivity contribute to cognitive impairments in Parkinson's disease2022OPENTitle: Hippocampal, basal ganglia and olfactory connectivity contribute to cognitive impairments in Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 57Issue #: 3Start Page: 511End Page: 526Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.15899Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9970048Citation Count: 13
-
OPENTitle: Differential involvement of Ras‐GRF1 and Ras‐GRF2 in L‐DOPA‐induced dyskinesiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 6Start Page: 662End Page: 678Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.202Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.202Citation Count: 20
- DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.2017RESTRICTEDTitle: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 131Issue #:Start Page: 116End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046Citation Count: 20
- Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies2022OPENTitle: Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategiesJournal Name: Neural Computing and ApplicationsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 8Start Page: 5603End Page: 5617Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00521-022-07256-8Best OA location URL: https://doi.org/10.1007/s00521-022-07256-8Citation Count: 22
- Single Molecule Fingerprinting Reveals Different Amplification Properties of α-Synuclein Oligomers and Preformed Fibrils in Seeding Assay2022OPENTitle: Single Molecule Fingerprinting Reveals Different Amplification Properties of α-Synuclein Oligomers and Preformed Fibrils in Seeding AssayJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 7Start Page: 883End Page: 896Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.1c00553Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.1c00553Citation Count: 13
-
OPENTitle: Hispanic Perspectives on Parkinson’s Disease Care and Research ParticipationJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 81Issue #: 2Start Page: 809End Page: 819Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jad-210231Best OA location URL: https://escholarship.org/uc/item/7sw467pnCitation Count: 20